Search Results

There are 145310 results for: content related to: Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review

  1. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia

    Drug and Alcohol Review

    Sarah Larney, Deborah Zador, Natasha Sindicich and Kate Dolan

    Version of Record online : 21 JUN 2016, DOI: 10.1111/dar.12442

  2. The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study


    Volume 109, Issue 8, August 2014, Pages: 1306–1317, Louisa Degenhardt, Sarah Larney, Jo Kimber, Natasa Gisev, Michael Farrell, Timothy Dobbins, Don J. Weatherburn, Amy Gibson, Richard Mattick, Tony Butler and Lucy Burns

    Version of Record online : 14 APR 2014, DOI: 10.1111/add.12536

  3. Harm reduction interventions for drug injectors or heroin users in Spain: expanding coverage as the storm abates


    Volume 107, Issue 6, June 2012, Pages: 1111–1122, Gregorio Barrio, María J. Bravo, M. Teresa Brugal, Mercedes Díez, Enrique Regidor, María José Belza, Luis de la Fuente and the Itinere Working Group

    Version of Record online : 11 FEB 2012, DOI: 10.1111/j.1360-0443.2011.03759.x

  4. Does exposure to opioid substitution treatment in prison reduce the risk of death after release? A national prospective observational study in England


    John Marsden, Garry Stillwell, Hayley Jones, Alisha Cooper, Brian Eastwood, Michael Farrell, Tim Lowden, Nino Maddalena, Chris Metcalfe, Jenny Shaw and Matthew Hickman

    Version of Record online : 1 MAR 2017, DOI: 10.1111/add.13779

  5. Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings


    Volume 107, Issue 11, November 2012, Pages: 1984–1995, Peter Vickerman, Natasha Martin, Katy Turner and Matthew Hickman

    Version of Record online : 12 JUL 2012, DOI: 10.1111/j.1360-0443.2012.03932.x

  6. You have free access to this content
    Mouse organic solute transporter α deficiency enhances renal excretion of bile acids and attenuates cholestasis


    Volume 51, Issue 1, January 2010, Pages: 181–190, Carol J. Soroka, Albert Mennone, Lee R. Hagey, Nazzareno Ballatori and James L. Boyer

    Version of Record online : 4 SEP 2009, DOI: 10.1002/hep.23265

  7. Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration


    Volume 107, Issue 2, February 2012, Pages: 372–380, Sarah Larney, Barbara Toson, Lucy Burns and Kate Dolan

    Version of Record online : 26 OCT 2011, DOI: 10.1111/j.1360-0443.2011.03618.x

  8. You have free access to this content
    Neurosteroid transport by the organic solute transporter OSTα–OSTβ

    Journal of Neurochemistry

    Volume 115, Issue 1, October 2010, Pages: 220–233, Fang Fang, Whitney V. Christian, Sadie G. Gorman, Mei Cui, Jiaoti Huang, Kim Tieu and Nazzareno Ballatori

    Version of Record online : 23 JUL 2010, DOI: 10.1111/j.1471-4159.2010.06920.x

  9. Factors influencing pharmacy services in opioid substitution treatment

    Drug and Alcohol Review

    Volume 32, Issue 4, July 2013, Pages: 426–434, Betty B. Chaar, Holly Wang, Carolyn A. Day, Jane R. Hanrahan, Adam R. Winstock and Romano Fois

    Version of Record online : 26 FEB 2013, DOI: 10.1111/dar.12032

  10. You have full text access to this OnlineOpen article
    Impact of opioid substitution therapy for Scotland's prisoners on drug-related deaths soon after prisoner release


    Volume 110, Issue 10, October 2015, Pages: 1617–1624, Sheila M. Bird, Colin M. Fischbacher, Lesley Graham and Andrew Fraser

    Version of Record online : 8 JUN 2015, DOI: 10.1111/add.12969

  11. A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence


    Volume 110, Issue 12, December 2015, Pages: 1975–1984, Natasa Gisev, Marian Shanahan, Don J. Weatherburn, Richard P. Mattick, Sarah Larney, Lucy Burns and Louisa Degenhardt

    Version of Record online : 23 SEP 2015, DOI: 10.1111/add.13073

  12. A comparative study of opioid substitution therapy utilisation among opioid-dependent men and women

    Drug and Alcohol Review

    Volume 33, Issue 5, September 2014, Pages: 499–505, Natasa Gisev, Louisa Degenhardt, Sarah Larney, Briony Larance, Amy Gibson, Jo Kimber and Lucy Burns

    Version of Record online : 20 MAY 2014, DOI: 10.1111/dar.12151

  13. You have free access to this content
    OSTα-OSTβ: A major basolateral bile acid and steroid transporter in human intestinal, renal, and biliary epithelia


    Volume 42, Issue 6, December 2005, Pages: 1270–1279, Nazzareno Ballatori, Whitney V. Christian, Jin Young Lee, Paul A. Dawson, Carol J. Soroka, James L. Boyer, Michael S. Madejczyk and Na Li

    Version of Record online : 29 NOV 2005, DOI: 10.1002/hep.20961

  14. The tyrosine phosphatase, OST-PTP, is expressed in mesenchymal progenitor cells early during skeletogenesis in the mouse

    Journal of Cellular Biochemistry

    Volume 93, Issue 4, 1 November 2004, Pages: 761–773, Laurie A. Yunker, Anne Undersander, Jane B. Lian, Gary S. Stein, Cathy S. Carlson and Laura J. Mauro

    Version of Record online : 11 AUG 2004, DOI: 10.1002/jcb.20183

  15. You have free access to this content
    Commentary on Larney (2010): A call to action—opioid substitution therapy as a conduit to routine care and primary prevention of HIV transmission among opioid-dependent prisoners


    Volume 105, Issue 2, February 2010, Pages: 224–225, SANDRA A. SPRINGER

    Version of Record online : 11 JAN 2010, DOI: 10.1111/j.1360-0443.2009.02893.x

  16. Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients

    Drug and Alcohol Review


    Version of Record online : 5 JAN 2011, DOI: 10.1111/j.1465-3362.2010.00274.x

  17. You have free access to this content

    Drug and Alcohol Review

    Volume 35, Issue S1, October 2016, Pages: 4–76,

    Version of Record online : 9 OCT 2016, DOI: 10.1111/dar.12484

  18. Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies


    Volume 111, Issue 7, July 2016, Pages: 1214–1223, Kim S. Betts, Gary Chan, Fairlie McIlwraith, Paul Dietze, Elizabeth Whittaker, Lucy Burns and Rosa Alati

    Version of Record online : 3 APR 2016, DOI: 10.1111/add.13339

  19. Death from liver disease in a cohort of injecting opioid users in a Swedish city in relation to registration for opioid substitution therapy

    Drug and Alcohol Review

    Anna Jerkeman, Anders Håkansson, Rebecca Rylance, Philippe Wagner, Marianne Alanko Blomé and Per Björkman

    Version of Record online : 30 MAY 2016, DOI: 10.1111/dar.12425

  20. Diversion and injection of buprenorphine–naloxone film two years post-introduction in Australia

    Drug and Alcohol Review

    Volume 35, Issue 1, January 2016, Pages: 83–91, Briony Larance, Richard Mattick, Robert Ali, Nicholas Lintzeris, Rebecca Jenkinson, Nancy White, Ivana Kihas, Rosemary Cassidy and Louisa Degenhardt

    Version of Record online : 9 OCT 2015, DOI: 10.1111/dar.12344